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Liver transplantation before 1 year of 
age 
Since 1981, 20 infants younger than 1 year of age received 26 orthotopic liver 
transplants. Immunosuppression was with cyclosporine and corticosteroids. 
Thirteen (65%) of the recipients were discharged from the hospital. To date, 12 
(60%) of the 20 recipients are surviving, with follow-up of 1 to 56 months 
(average 14 months). The 5-year actuarial survival is 53.8%. The allograft liver 
function in the majority of surviving infants is excellent. The predominant 
causes of mortality were primary nonfunction of the allograft (three patients) 
and sepsis (three). Major morbidity was caused by hepatic artery thrombosis 
(five patients), gastrOintestinal complications (six), biliary tract complications 
(five), and bacterial and viral infections (13). Six patients underwent retrans-
plantation; three of these six survived. Results could be improved by prevention 
of hepatic artery thrombosis, by decreasing the incidence of sepsis, and by 
procurement of more and better suited pediatric donors. (J PEDIATR 1987;110: 
545-8) 
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METHODS 
141 
The successful use of orthotopic liver transplantation for 
treatment of end-stage liver disease in the pediatric popu-
lation has been reported. I 3 Transplantation in very small 
children has been uncommon because of the scarcity of 
suitable donors and because an increased incidencc of 
technical difficulties is to be expected when anastomosing 
tiny structures. Although the number of centers perform-
ing liver transplants is slowly increasing, many of these 
small patients are not accepted as candidates. We report 
our experience with 20 patients younger than 1 year of age 
undergoing liver transplantation at the Children's Hospit, 
of Pittsburgh. 
Between March 1980 and June 30, 1986,612 patients 
underwent liver transplantation under immunosuppression 
with cyclosporine and prednisone; 241 were pediatric 
patients, including 20 younger than 1 year of age. The first 
transplant in this group was performed in November 1981. 
Fourteen of the 20 were girls; their age range was 3 to 11 
months, and weight 5.2 to 9.7 kg (mean 7 kg). The most 
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common indication for transplantation was biliary atresia 
(12 patients); other diagnoses included tyrosinemia (two 
patients) and ai-antitrypsin deficiency, neonatal hemo-
chromatosis, fulminant hepatitis, intrahepatic cholestasis, 
neonatal hepatitis, and type IV glycogen storage disease 
(one each). All patients with biliary atresia had undergone 
hepatic portoenterostomy (Kasai procedure).4 The impor-
tant clinical features of these patients are shown in Table I. 
All had significant irreversible liver disease, average biliru-
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Table I. Clinical features of patients requiring liver 
transplantation before 1 year of age 
Jaundice 
Ascites 
Severe 
'\1ild to moderate 
Variceal hemorrhage 
Major 
Minor 
Coagulopathy (prothrombin 
time 2:: 20 sec) 
Encephalopathy 
n 
20 
6 
11 
4 
4 
9 
6 
% 
100 
30 
55 
20 
20 
45 
30 
Table II. Influence of age on survival after liver 
transplantation before 1 year of age 
Age No. of No. 
(mo) patients alive 
4-6 3 2 
7-9 8 5 
10- < 12 
--.2 ~ 
20 12 
bin 21 mg/dL (range 3 to 45 mg/dL), average prothrom-
bin time 21 seconds (range 12 to 60 seconds vs control 11 
seconds), and serum albumin concentration 2.8 g/dL 
(range 1.1 to 4.8 g/dL). The majority were critically ill 
and considered to have the highest priority on the waiting 
list. Matching was done mainly by size and blood type; 
however, nine of 26 grafts came from donors of different 
blood groups: ° to B. A to B, B to 0, and A to 0, two 
patients each, and AS to A, one patient. No attempt was 
made to match human leukocyte antigen loci preoperative-
ly. 
The donor operation differed little from that used for 
adult multiple organ harvesting, with the following excep-
tion' ": when possible, the celiac axis and superior mesen-
teric artery were removed in continuity with the entire 
abdominal and thoracic aorta; this segment of aorta was 
sometimes used as a conduit. 
The transplant operation has become well standardized 
since the original report.' In this group of patients, venous 
bypass was not utilized. The small size of the vascular 
anastomoses required the use of loop magnification and the 
"growth factor" technique to prevent purse-stringing and 
subsequent stricture.' The arterialization of the graft was 
achieved either by end-to-end anastomosis or by conduit 
from the infrarenal aorta to the graft hepatic artery using 
donor thoracic or abdominal aorta, or iliac artery. A 
Roux-en- Y choledochojejunostomy, over a 3 or 5 French 
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Table III. Current status of 12 living recipients of liver 
transplants before 1 year of age 
Current 
status 
Doing very well 
Biliary strictures 
Chronic rejection 
No. of 
patients Comment 
8 One patient has hepatitis B 
3 Strictures in two patients have 
been d i Ia ted: no stents in 
place 
One patient with nondilatable 
stricture is awaiting 
retransplantation 
May need retransplantation 
soon 
stent, was used for biliary reconstruction. In some cases the 
previously constructed Roux limb could be used. Postoper-
ative immunosuppression was with cyclosporine and corti-
costeroids. Episodes of severe rejection in the early opera-
tions of this series were treated with increased doses of 
steroids or occasionally with antithymocyte globulin 
(ATGAM, Upjohn Company, Kalamazoo, Mich.). 
Recently, OKT3 (Ortho Pharmaceutical Corp., Raritan, 
N.J.), a monoclonal antibody, has been used in place of the 
anti thymocyte globulin. 
RESULTS 
The overall survival rate is 60%, with follow-up of I to 
56 months (average 14 months). The influence of age on 
survival is shown in Table 11. All but one death occurred 
during the initial hospitalization for transplantation. Thir-
teen of the 20 patients were discharged from the hospital, 
and of these 12 are alive. One patient with excellent 
allograft function died of aspiration pneumonitis 3 months 
after discharge. The cause of aspiration was probably the 
result of a neurologic deficit caused by a subarachnoid 
hemorrhage 2 months before transplantation. At that time 
she had a severe coagulopathy requiring frequent infusions 
of fresh frozen plasma. The underlying disease was tyrosi-
nemia. Another patient with a controlled biliary fistula and 
normal hepatic function might need retransplantation in 
the future. In seven of 12 survivors, results of liver 
functions tests were normal. Three other patients with 
normal serum bilirubin levels «1 mg/dL) had slightly 
abnormal transaminase activities, between 40 and 100 
IU /L. One of these infants had intrahepatic biliary stric-
tures secondary to arterial thrombosis, and the other two 
had mild resolving rejection. Two patients had abnormal 
bilirubin and transaminase values secondary to intrahepat-
ic strictures and chronic rejection, respectively (Table III). 
The 5-year actuarial survival is 53.5% (Figure). Although 
four patients are below the fifth percentile for height, all 
Volume 1 \0 
Number 4 
Table IV. Causes of death in intra- and postoperative 
period 
Major cause 
of death 
Primary non function of 
allograft 
Metabolic acidosis, 
hyperkalemia 
Sepsis (Candida, 
Clostridium. 
Pseudomonas, 
parainfluenza type 3 
Aspiration pneulllonitis 
No. of 
patients 
3 
3 
Survival 
(days) 
7,8,27 
Intraoperative 
7, 30, 44 
289 
have shown linear growth. Motor function in all infants is 
similar to that of normal patients. 
Seven patients died during hospitalization for transplan-
tation (Table IV). One intraoperative death was in an 
infant who was very ill before the transplantation, with 
sepsis, acidosis, hyperkalemia, and severe coagulopathy. 
Another patient died after a complicated course beginning 
with right colon perforation and arterial thrombosis of the 
first allograft. After retransplantation a biliary leak, sep-
sis, and bleeding ultimately led to his death. Two other 
patients died of septic complications, one from peritonitis 
secondary to an intestinal perforation and the other from 
pneumonia caused by Pseudomonas and parainfluenza 
type 3 virus. Three patients died from primary nonfunction 
of the allograft with intraoperative coagulopathy, postop-
erative renal impairment, fluid retention, and cerebral 
edema, followed by the onset of septic complications after 
about 1 week. Only one patient with primary graft 
nonfunction received a retransplant: septic complications 
ultimately led to her death four weeks after the original 
procedure. Six patients underwent retransplantation, three 
because of rejection, two because of arterial thrombosis, 
and one after primary nonfunction of the first allograft. 
Three of these six patients are surviving. 
Of the nine grafts crossing the ABO groups. four are 
functioning well, two were lost to rejection, one was lost to 
primary graft nonfunction, and two others were lost to 
extrahepatic causes. 
The average operative time was 9Vz hours, and the 
estimated blood loss averaged 5.9 blood volumes. Postoper-
ative complications among survivors were numerous, as 
indicated by the average hospital stay of 70 days (range 27 
to 180 days). Many complications were minor, and in-
cluded mild rejection, wound infection, diarrhea, and 
fever. Major postoperative complications included severe 
rejection (seven patients), arterial thrombosis, biliary 
obstruction or fistula, and intestinal perforation (five 
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Figure. Five-year actuarial survival for 20 liver transplant recip· 
ients younger than 1 year of age. 
each), primary graft non function (three), and infections 
(13) . 
A majority of the children have had rejection, but only 
in three was it severe enough to warrant retransplantation, 
and was associated with a severe cytomegalovirus infection 
in one patient in whom full immunosuppression could not 
be maintained. All three recipients are alive, but one has 
chronic rejection and will probably need retransplantation. 
In three of the five children with hepatic artery thrombosis, 
high transaminase activity and gram-negative bacteremia 
developed. Diagnosis was usually made by ultrasound and 
confirmed by angiography. Of these five patients, two have 
undergone retransplantation, another is awaiting retrans-
plantation, and the other two have no indications for 
rctransplanta tion. 
Necrosis of the bile duct after thrombosis caused three 
of the five biliary complications, including strictures. Most 
of the strictures could be percutaneously dilated. Intestinal 
problems included perforation in five patients and bleeding 
requiring resection in one. Hepatitis caused by cytomega-
lovirus and by hepatitis B was a cause of postoperative 
hepatic dysfunction in two patients. 
DISCUSSION 
The overall actuarial survival after liver transplantation 
in infants is similar to the 64% overall rate of 5-year 
survival obtained in children of all ages reported from this 
center earlier. I They are superior to the results obtained in 
the precyclosporine era.9 In a series of eight patients 
ranging in age from 8 to 19 months (longest follow-up 9 
months), Ascher and Najarian3 reported five survivors; two 
of the three deaths were related to poor function of the 
allograft. Similarly, in our series of 20 patients, primary 
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nonfunction of the allograft was the predominant contrib-
uting factor in three of eight deaths. Sepsis with a variety 
of microorganisms was common in patients who died. 
Probably one of these deaths could have been avoided (the 
patient with a small bowel perforation should have had an 
earlier diagnosis and surgery). Age has not had any impact 
on survival in these infants. However, a persistent problem 
in pediatric liver transplantation is the unavailability of 
small donors. Some of the patients who died of primary 
graft non function and thrombosis of the hepatic artery 
might have been saved by prompt retransplantation had 
organs been available. The scarcity of donors also led us to 
use donors from different blood groups, and this practice 
has resulted in little or no deleterious consequences as 
reported elsew here.1O 
The morbidity of liver replacement in these small 
recipients has been considerable. The incidence of major 
postoperative complications is higher than that of a previ-
ous series that included older patients. l The increased 
number of complications in this small pediatric population 
is explained in part by the small size of the structures with 
which to work. In the cause of arterial thrombosis, other 
factors may also be implicated, namely infection, unrecog-
nized intimal flap, and rejection. Rejection can create high 
resistance and low flow, leading to thrombosis. Recently 
we have begun using dextran 40, aspirin, and heparin to 
decrease the incidence of hepatic arterial thrombosis in 
these small recipients, but it is too early to assess the 
results. 
In children the recipient hepatectomy was generally 
easier than in adults, except in those patients who had had 
multiple previous laparotomies, in whom adhesions made 
surgery tedious and there was an increase in intestinal 
complications. The judicious use of corticosteroids and 
improvement in nutritional status explain the good growth 
of liver transplant recipients given cyclosporine. ll 
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Infants with end-stage liver disease should not be denied 
the opportunity of receiving hepatic replacement, despite 
the high complication rate observed in this high-risk group. 
The survival, and growth and development of these small 
recipients have been satisfactory thus far. 
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